Bavarian Research Foundation supports the development of an immunosuppressive PASylated antibody fragment to support cardiac xenotransplantation
Munich, September 28, 2022 – A research consortium composed…
Akari Therapeutics Announces Positive Results from Recent Pre-Clinical Studies of Investigational PASylated® Nomacopan That Support the Potential to Advance Research Toward IND/IMPD for Clinical Trials in Geographic Atrophy
NEW YORK and LONDON, July 28, 2022 (GLOBE NEWSWIRE) -- Akari…
Rentschler Biopharma and XL-protein demonstrate efficient production of a hyperactive PASylated DNase I with extended half-life
Hyperactive DNase I modified with XL-protein’s PASylation®…